Xeriant Financial Statements From 2010 to 2025
| XERI Stock | USD 0.01 0.0005 4.17% |
Check Xeriant financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Xeriant's main balance sheet or income statement drivers, such as , as well as many indicators such as . Xeriant financial statements analysis is a perfect complement when working with Xeriant Valuation or Volatility modules.
Xeriant |
Xeriant OTC Stock Shares Owned By Institutions Analysis
Xeriant's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Current Xeriant Shares Owned By Institutions | 0.01 % |
Most of Xeriant's fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Xeriant is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
| Competition |
Based on the latest financial disclosure, 0.011% of Xeriant are shares owned by institutions. This is 99.98% lower than that of the Industrials sector and 99.98% lower than that of the Aerospace & Defense industry. The shares owned by institutions for all United States stocks is 99.97% higher than that of the company.
Xeriant Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Xeriant's current stock value. Our valuation model uses many indicators to compare Xeriant value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Xeriant competition to find correlations between indicators driving Xeriant's intrinsic value. More Info.Xeriant is rated third in return on equity category among its peers. It is rated fourth in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Xeriant by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Xeriant's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Xeriant Financial Statements
Investors use fundamental indicators, such as Xeriant's revenue or net income, to determine how well the company is positioned to perform in the future. Although Xeriant's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Xeriant, Inc. operates as an aerospace technology and advanced materials holding company in the United States. Xeriant, Inc. was incorporated in 2009 and is headquartered in Boca Raton, Florida. Xeriant operates under Aerospace Defense classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Xeriant OTC Stock
Xeriant financial ratios help investors to determine whether Xeriant OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Xeriant with respect to the benefits of owning Xeriant security.